Drugs / Septra
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SEPTRA | — | 1973-07-30 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial · 1 met primary | ||||||
| — | NCT02593903 | Mar 2014 → Jun 2017 | hypospadias | Medical College of Wisconsin | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT00829686 Comparator | Jun 2008 | abscess | 59th Medical Wing | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Septra | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02593903 ↗ |
| Route | Oral | “(800/125) PO BID X 7 days” NCT00829686 ↗ |